Laura Berron-Ruiz
Overview
Explore the profile of Laura Berron-Ruiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valerio-Gomez V, Perez-Blanco U, Velazquez-Samano G, Velasco-Medina A, Albarran A, Sanchez I, et al.
Biomedica
. 2025 Jan;
44(Sp. 2):22-30.
PMID: 39836847
STAT1 is a cytoplasmic transcription factor associated with cell growth regulation, differentiation, proliferation, metabolism, and apoptosis. IFN-mediated JAK/STAT signaling pathway is involved in eliminating intracellular pathogens and viruses.
However, pathogenic...
2.
Guadalupe V, Abigail J S, Patricia O, Andrea H, Selma S, Marco A Y, et al.
Allergol Immunopathol (Madr)
. 2024 Sep;
52(5):94-102.
PMID: 39278858
Background: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by defective antibody production and impaired differentiation of B cells. B cell proliferation is an essential step for antibody synthesis....
3.
Fuentes-Lara E, Arce-Estrada G, Bojalil-Cabildo A, Yamazaki-Nakashimada M, Espinosa-Padilla S, Gamez-Gonzalez L, et al.
Allergol Immunopathol (Madr)
. 2023 Nov;
51(6):89-96.
PMID: 37937501
Background: Leukocyte adhesion deficiency type 1 (LAD-1) is an inborn error of immunity characterized by a defect in leukocyte trafficking. Methods: Patients with clinical suspicion of LAD-1 were referred to...
4.
Herrera-Sanchez D, Lopez-Moreno N, Berron-Ruiz L, Ramos-Blas G, Catana-Hernandez R, OFarrill-Romanillos P
Rev Med Inst Mex Seguro Soc
. 2023 Nov;
61(Suppl 3):S484-S491.
PMID: 37935008
Introduction: Up to 25% of patients with common variable immunodeficiency (CVID) debut with autoimmunity, which is related to the Freiburg classification, which is based on flow cytometry. Objective: to determine...
5.
Coronado-Hernandez K, Campos-Tellez H, Cortes-Grimaldo R, Macias-Robles A, Estrada-Garcia C, Barrios-Diaz B, et al.
Rev Alerg Mex
. 2023 May;
69(4):214-219.
PMID: 37218048
Introduction: Hyper-IgM syndrome is an innate error of immunity in which there is a defect in change of isotype of immunoglobulins, with decreased values of IgG, IgA, and IgE, but...
6.
Carrillo-Tapia E, Espinosa-Padilla S, Perez-Perez D, Gonzalez-Serrano M, Berron-Ruiz L, Espinosa-Rosales F, et al.
Genet Test Mol Biomarkers
. 2022 Apr;
26(4):220-227.
PMID: 35394812
Fragment analysis of exon 1 of the human androgen receptor, known as HUMARA, is a polymerase chain reaction (PCR)-based method for detecting X-linked agammaglobulinemia (XLA) carriers. This method takes advantage...
7.
Olguin-Calderon D, Velasquez-Ortiz M, Huerta-Robles H, Lopez-Herrera G, Segura-Mendez N, OFarrill-Romanillos P, et al.
Hum Immunol
. 2022 Feb;
83(5):428-436.
PMID: 35177260
Background: Common Variable Immunodeficiency (CVID) is a heterogeneous disorder characterized by defective B cell differentiation and antibody production. Interleukin (IL)-21 activates STAT3, a potent regulator of B cell differentiation into...
8.
Berron-Ruiz L
Rev Alerg Mex
. 2021 Jun;
68(1):48-64.
PMID: 34148328
Common variable immunodeficiency (CVID) is the most prevalent symptomatic primary immunodeficiency with an estimated prevalence of one in 10,000 to 50,000 inhabitants. This heterogeneous disease is characterized by decreased levels...
9.
Lugo-Reyes S, Pastor N, Gonzalez-Serrano E, Yamazaki-Nakashimada M, Scheffler-Mendoza S, Berron-Ruiz L, et al.
J Clin Immunol
. 2021 Jun;
41(7):1708.
PMID: 34136975
No abstract available.
10.
Lugo-Reyes S, Pastor N, Gonzalez-Serrano E, Yamazaki-Nakashimada M, Scheffler-Mendoza S, Berron-Ruiz L, et al.
J Clin Immunol
. 2021 May;
41(6):1291-1302.
PMID: 33954879
Mutations in recombinase activating genes 1 and 2 (RAG1/2) result in human severe combined immunodeficiency (SCID). The products of these genes are essential for V(D)J rearrangement of the antigen receptors...